Prevention of type 2 diabetes through remotely administered lifestyle programs: A systematic review.
Prevention of type 2 diabetes through remotely administered lifestyle programs: A systematic review.
复制标题
通过远程管理的生活方式计划预防 2 型糖尿病:系统评价。
DOI:
10.1016/j.cct.2022.106817
复制
发表时间:
2022
影响因子:
2.2
通讯作者:
Tobias,DeirdreK
中科院分区:
文献类型:
--
作者:
Villegas,Valaree;Shah,Alisha;Manson,JoAnnE;Tobias,DeirdreK
BackgroundAlthough effective in reducing the risk of type 2 diabetes (T2D), in-person lifestyle modification programs have been underutilized. To minimize barriers related to convenience and accessibility, recent research has focused on developing virtual or remote interventions that may have comparable or greater efficacy in promoting lifestyle changes and reducing the risk of T2D. We conducted a systematic review to evaluate the efficacy of remotely-administered lifestyle interventions on preventing T2D.MethodsWe searched an electronic database by using keywords, and a web-based software platform was used to screen articles and extract data in duplicate. We included articles with adolescent/adult participant populations who had prediabetes or were at elevated risk of diabetes, remotely-administered lifestyle interventions on T2D prevention, and changes in glycemic traits. We excluded trials of patients with prevalent T2D, interventions that included medications, and those not relevant to our outcomes of interest.ResultsA total of 8 publications were included in this systematic review. Six papers indicated significant reductions in weight and/or glycemic biomarkers such as HbA1c and fasting glucose. All studies reported that remotely-administered interventions were convenient for participants, and one publication reported that participation of the online DPP group was significantly higher than the in-person DPP.ConclusionThese findings suggest that remotely-administered lifestyle interventions for T2D prevention could be a promising participant-friendly alternative to in-person programs, with efficacy for reducing weight and glycemic biomarkers.